Literature DB >> 31170704

The influence of lifestyle factors on fecal volatile organic compound composition as measured by an electronic nose.

Sofie Bosch1, Jesse Pm Lemmen, Renée Menezes, René van der Hulst, Johan Kuijvenhoven, Pieter Cf Stokkers, Tim Gj de Meij, Nanne Kh de Boer.   

Abstract

INTRODUCTION: Fecal volatile organic compounds (VOCs) are gaseous metabolic products which are increasingly considered potential non-invasive biomarkers for the detection of various (gastrointestinal) diseases. The influence of lifestyle factors on fecal VOC patterns remains unexplored but is of importance prior to implementation of VOC analysis as a diagnostic tool. The aim of this study was to investigate the effects of age, gender, body mass index, smoking status, dietary preferences, medication use and co-morbidity on fecal VOC patterns.
METHODS: For this study, fecal samples of patients undergoing a colonoscopy were collected prior to endoscopy. All participants completed a questionnaire on lifestyle factors, co-morbidity and medication use. Patients without colonic abnormalities were included in this study. Fecal VOC patterns were analyzed by means of an electronic nose (eNose) device (Cyranose® 320).
RESULTS: From the 1039 participants willing to participate in the initial study, 211 were eligible as controls. All unique lifestyle variables investigated in this study affected the fecal VOC composition. The strongest influences were caused by low BMI, a vegetarian diet and an active smoking status, whereas the least influence was found for the variables gender, age > 55 years and previous smokers. DISCUSSION: Age, gender, BMI, smoking habits, dietary preferences, co-morbidity and medication use all have unique effects on fecal VOC composition. Future studies should carefully consider this influence on VOC outcome when defining VOC signatures as biomarker for diagnostic purposes.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31170704     DOI: 10.1088/1752-7163/ab2775

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  6 in total

1.  Short-Term Effect of Cigarette Smoke on Exhaled Volatile Organic Compounds Profile Analyzed by an Electronic Nose.

Authors:  Silvano Dragonieri; Vitaliano Nicola Quaranta; Enrico Buonamico; Claudia Battisti; Teresa Ranieri; Pierluigi Carratu; Giovanna Elisiana Carpagnano
Journal:  Biosensors (Basel)       Date:  2022-07-13

2.  Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.

Authors:  Kelly E van Keulen; Maud E Jansen; Ruud W M Schrauwen; Jeroen J Kolkman; Peter D Siersema
Journal:  Aliment Pharmacol Ther       Date:  2019-12-20       Impact factor: 8.171

3.  A novel electronic nose for the detection and classification of pesticide residue on apples.

Authors:  Yong Tang; Kunli Xu; Bo Zhao; Meichao Zhang; Chenhui Gong; Hailun Wan; Yuanhui Wang; Zepeng Yang
Journal:  RSC Adv       Date:  2021-06-11       Impact factor: 3.361

Review 4.  Are Volatile Organic Compounds Accurate Markers in the Assessment of Colorectal Cancer and Inflammatory Bowel Diseases? A Review.

Authors:  Filippo Vernia; Marco Valvano; Stefano Fabiani; Gianpiero Stefanelli; Salvatore Longo; Angelo Viscido; Giovanni Latella
Journal:  Cancers (Basel)       Date:  2021-05-13       Impact factor: 6.639

5.  Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.

Authors:  Sofia El Manouni El Hassani; Sofie Bosch; Jesse P M Lemmen; Marina Brizzio Brentar; Ibrahim Ayada; Alfian N Wicaksono; James A Covington; Marc A Benninga; Nanne K H de Boer; Tim G J de Meij
Journal:  Sensors (Basel)       Date:  2019-10-16       Impact factor: 3.576

6.  The Influence of Smoking Status on Exhaled Breath Profiles in Asthma and COPD Patients.

Authors:  Stefania Principe; Job J M H van Bragt; Cristina Longo; Rianne de Vries; Peter J Sterk; Nicola Scichilone; Susanne J H Vijverberg; Anke H Maitland-van der Zee
Journal:  Molecules       Date:  2021-03-04       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.